129 related articles for article (PubMed ID: 38902121)
1. Reducing or Increasing Overtreatment? How Do We Measure the Impact of Magnetic Resonance Imaging-targeted Biopsy on Prostate Cancer Mortality?
Taneja SS
Eur Urol; 2024 Jun; ():. PubMed ID: 38902121
[No Abstract] [Full Text] [Related]
2. Does Overgrading on Targeted Biopsy of Magnetic Resonance Imaging-visible Lesions in Prostate Cancer Lead to Overtreatment?
Baboudjian M; Diamand R; Uleri A; Beauval JB; Touzani A; Roche JB; Lacetera V; Roumeguère T; Simone G; Benamran D; Fourcade A; Gondran-Tellier B; Fiard G; Peltier A; Ploussard G
Eur Urol; 2024 Mar; ():. PubMed ID: 38494379
[TBL] [Abstract][Full Text] [Related]
3. Effects of Magnetic Resonance Imaging Targeting on Overdiagnosis and Overtreatment of Prostate Cancer.
Vickers AJ
Eur Urol; 2021 Nov; 80(5):567-572. PubMed ID: 34294510
[TBL] [Abstract][Full Text] [Related]
4. Optimization of prostate biopsy: the role of magnetic resonance imaging targeted biopsy in detection, localization and risk assessment.
Bjurlin MA; Meng X; Le Nobin J; Wysock JS; Lepor H; Rosenkrantz AB; Taneja SS
J Urol; 2014 Sep; 192(3):648-58. PubMed ID: 24769030
[TBL] [Abstract][Full Text] [Related]
5. Magnetic resonance imaging targeted biopsy in biopsy-naïve patients and the risk of overtreatment in prostate cancer: a grading issue.
Jabbour T; Peltier A; Rocq L; Sirtaine N; Lefebvre Y; Bourgeno H; Baudewyns A; Roumeguère T; Diamand R
BJU Int; 2024 Apr; 133(4):432-441. PubMed ID: 37943114
[TBL] [Abstract][Full Text] [Related]
6. Role of magnetic resonance imaging in defining a biopsy strategy for detection of prostate cancer.
Ridout AJ; Kasivisvanathan V; Emberton M; Moore CM
Int J Urol; 2014 Jan; 21(1):5-11. PubMed ID: 24000944
[TBL] [Abstract][Full Text] [Related]
7. Prostate MRI can reduce overdiagnosis and overtreatment of prostate cancer.
Rosenkrantz AB; Taneja SS
Acad Radiol; 2015 Aug; 22(8):1000-6. PubMed ID: 25791578
[TBL] [Abstract][Full Text] [Related]
8. Targeted biopsy in the detection of prostate cancer using an office based magnetic resonance ultrasound fusion device.
Sonn GA; Natarajan S; Margolis DJ; MacAiran M; Lieu P; Huang J; Dorey FJ; Marks LS
J Urol; 2013 Jan; 189(1):86-91. PubMed ID: 23158413
[TBL] [Abstract][Full Text] [Related]
9. The Institutional Learning Curve of Magnetic Resonance Imaging-Ultrasound Fusion Targeted Prostate Biopsy: Temporal Improvements in Cancer Detection in 4 Years.
Meng X; Rosenkrantz AB; Huang R; Deng FM; Wysock JS; Bjurlin MA; Huang WC; Lepor H; Taneja SS
J Urol; 2018 Nov; 200(5):1022-1029. PubMed ID: 29886090
[TBL] [Abstract][Full Text] [Related]
10. Accuracy of Transperineal Targeted Prostate Biopsies, Visual Estimation and Image Fusion in Men Needing Repeat Biopsy in the PICTURE Trial.
Simmons LAM; Kanthabalan A; Arya M; Briggs T; Barratt D; Charman SC; Freeman A; Hawkes D; Hu Y; Jameson C; McCartan N; Moore CM; Punwani S; van der Muelen J; Emberton M; Ahmed HU
J Urol; 2018 Dec; 200(6):1227-1234. PubMed ID: 30017964
[TBL] [Abstract][Full Text] [Related]
11. Identification of threshold prostate specific antigen levels to optimize the detection of clinically significant prostate cancer by magnetic resonance imaging/ultrasound fusion guided biopsy.
Shakir NA; George AK; Siddiqui MM; Rothwax JT; Rais-Bahrami S; Stamatakis L; Su D; Okoro C; Raskolnikov D; Walton-Diaz A; Simon R; Turkbey B; Choyke PL; Merino MJ; Wood BJ; Pinto PA
J Urol; 2014 Dec; 192(6):1642-8. PubMed ID: 25117476
[TBL] [Abstract][Full Text] [Related]
12. Impact of Magnetic Resonance Imaging Targeting on Pathologic Upgrading and Downgrading at Prostatectomy: A Systematic Review and Meta-analysis.
Weinstein IC; Wu X; Hill A; Brennan D; Omil-Lima D; Basourakos S; Brant A; Lewicki P; Al Hussein Al Awamlh B; Spratt D; Bittencourt LK; Scherr D; Zaorsky NG; Nagar H; Hu J; Barbieri C; Ponsky L; Vickers AJ; Shoag JE
Eur Urol Oncol; 2023 Aug; 6(4):355-365. PubMed ID: 37236832
[TBL] [Abstract][Full Text] [Related]
13. Impact of Relative Volume Difference Between Magnetic Resonance Imaging and Three-dimensional Transrectal Ultrasound Segmentation on Clinically Significant Prostate Cancer Detection in Fusion Magnetic Resonance Imaging-targeted Biopsy.
Lenfant L; Beitone C; Troccaz J; Beaugerie A; Rouprêt M; Seisen T; Renard-Penna R; Voros S; Mozer PC
Eur Urol Oncol; 2024 Jun; 7(3):430-437. PubMed ID: 37599199
[TBL] [Abstract][Full Text] [Related]
14. Defining a Cohort that May Not Require Repeat Prostate Biopsy Based on PCA3 Score and Magnetic Resonance Imaging: The Dual Negative Effect.
Perlis N; Al-Kasab T; Ahmad A; Goldberg E; Fadak K; Sayyid R; Finelli A; Kulkarni G; Hamilton R; Zlotta A; Ghai S; Fleshner N
J Urol; 2018 May; 199(5):1182-1187. PubMed ID: 29175542
[TBL] [Abstract][Full Text] [Related]
15. Magnetic resonance imaging/transrectal ultrasound fusion-targeted prostate biopsy using three-dimensional ultrasound-based organ-tracking technology: Initial experience in Japan.
Yamada Y; Fujihara A; Shiraishi T; Ueda T; Yamada T; Ueno A; Inoue Y; Kaneko M; Kamoi K; Hongo F; Okihara K; Ukimura O
Int J Urol; 2019 May; 26(5):544-549. PubMed ID: 30793385
[TBL] [Abstract][Full Text] [Related]
16. Magnetic resonance imaging/transrectal ultrasonography fusion targeted prostate biopsy finds more significant prostate cancer in biopsy-naïve Japanese men compared with the standard biopsy.
Fujii S; Hayashi T; Honda Y; Terada H; Akita R; Kitamura N; Ueda E; Han X; Ueno T; Miyamoto S; Kitano H; Inoue S; Teishima J; Abdi H; Awai K; Takeshima Y; Sentani K; Yasui W; Matsubara A
Int J Urol; 2020 Feb; 27(2):140-146. PubMed ID: 31733635
[TBL] [Abstract][Full Text] [Related]
17. Transperineal magnetic resonance image targeted prostate biopsy versus transperineal template prostate biopsy in the detection of clinically significant prostate cancer.
Kasivisvanathan V; Dufour R; Moore CM; Ahmed HU; Abd-Alazeez M; Charman SC; Freeman A; Allen C; Kirkham A; van der Meulen J; Emberton M
J Urol; 2013 Mar; 189(3):860-6. PubMed ID: 23063807
[TBL] [Abstract][Full Text] [Related]
18. A Multicenter Study of the Clinical Utility of Nontargeted Systematic Transperineal Prostate Biopsies in Patients Undergoing Pre-Biopsy Multiparametric Magnetic Resonance Imaging.
Connor MJ; Eldred-Evans D; van Son M; Hosking-Jervis F; Bertoncelli Tanaka M; Reddy D; Bass EJ; Powell L; Ahmad S; Pegers E; Joshi S; Sri D; Wong K; Tam H; Hrouda D; Qazi H; Gordon S; Winkler M; Ahmed HU
J Urol; 2020 Dec; 204(6):1195-1201. PubMed ID: 32516029
[TBL] [Abstract][Full Text] [Related]
19. Systematic and MRI-Cognitive Targeted Transperineal Prostate Biopsy Accuracy in Detecting Clinically Significant Prostate Cancer after Previous Negative Biopsy and Persisting Suspicion of Malignancy.
Vėželis A; Platkevičius G; Kinčius M; Gumbys L; Naruševičiūtė I; Briedienė R; Petroška D; Ulys A; Jankevičius F
Medicina (Kaunas); 2021 Jan; 57(1):. PubMed ID: 33435132
[No Abstract] [Full Text] [Related]
20. Comparative analysis of transperineal template saturation prostate biopsy versus magnetic resonance imaging targeted biopsy with magnetic resonance imaging-ultrasound fusion guidance.
Radtke JP; Kuru TH; Boxler S; Alt CD; Popeneciu IV; Huettenbrink C; Klein T; Steinemann S; Bergstraesser C; Roethke M; Roth W; Schlemmer HP; Hohenfellner M; Hadaschik BA
J Urol; 2015 Jan; 193(1):87-94. PubMed ID: 25079939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]